Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hoelzer

Showing results (381-390 of 415) with videos related to

Pageof 42
Sort By:
Leukemia|December 26, 2001
Prospective BCR-ABL analysis by polymerase chain reaction (RT-PCR) in adult acute B-lineage lymphoblastic leukemia: reliability of RT-nested-PCR and comparison to cytogenetic dataB Gleissner, H Rieder, E Thiel, et al.
Blood|January 7, 1998
A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. The International Acute Myeloid Leukemia Study GroupG Heil, D Hoelzer, M A Sanz, et al.
Annals of Hematology|October 8, 2003
Prior and concurrent administration of recombinant human megakaryocyte growth and development factor in patients receiving consolidation chemotherapy for de novo acute myeloid leukemia--a randomized, placebo-controlled, double-blind safety and efficacy studyK Geissler, J A Liu Yin, A Ganser, et al.
Leukemia & Lymphoma|October 8, 1999
Intermittent 2-hour-infusion of cladribine as first-line therapy or in first relapse of progressive advanced low-grade and mantle cell lymphomasM J Rummel, K U Chow, E Jäger, et al.
Praxis|April 13, 1999
[Treatment of adult acute lymphoblastic leukemia]N Gökbuget, R Arnold, T Büchner, et al.
Leukemia|January 23, 2009
The homeobox gene CDX2 is aberrantly expressed and associated with an inferior prognosis in patients with acute lymphoblastic leukemiaS Thoene, V P S Rawat, B Heilmeier, et al.
Der Internist|October 1, 1996
[Acute lymphatic leukemia of the adult. Diagnosis, risk groups and therapy]D Hoelzer, N Gökbuget, R Arnold, et al.
Blood Cancer Journal|July 26, 2012
Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutationsM Neumann, S Heesch, N Gökbuget, et al.
Blood|November 26, 1999
A randomized, double-blind, placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as an adjunct to chemotherapy for adults with de novo acute myeloid leukemiaE Archimbaud, O G Ottmann, J A Yin, et al.
Vnitrni Lekarstvi|April 17, 2010
[Treatment of adult acute lymphoblastic leukemia according to GMALL 07/2003 study protocol in the Czech Republic - the first experience]F Folber, C Sálek, M Doubek, et al.
Pageof 42

Showing results (381-390 of 415) with videos related to

Sort By:
Pageof 42
Leukemia|December 26, 2001
Prospective BCR-ABL analysis by polymerase chain reaction (RT-PCR) in adult acute B-lineage lymphoblastic leukemia: reliability of RT-nested-PCR and comparison to cytogenetic dataB Gleissner, H Rieder, E Thiel, et al.
Blood|January 7, 1998
A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. The International Acute Myeloid Leukemia Study GroupG Heil, D Hoelzer, M A Sanz, et al.
Annals of Hematology|October 8, 2003
Prior and concurrent administration of recombinant human megakaryocyte growth and development factor in patients receiving consolidation chemotherapy for de novo acute myeloid leukemia--a randomized, placebo-controlled, double-blind safety and efficacy studyK Geissler, J A Liu Yin, A Ganser, et al.
Leukemia & Lymphoma|October 8, 1999
Intermittent 2-hour-infusion of cladribine as first-line therapy or in first relapse of progressive advanced low-grade and mantle cell lymphomasM J Rummel, K U Chow, E Jäger, et al.
Praxis|April 13, 1999
[Treatment of adult acute lymphoblastic leukemia]N Gökbuget, R Arnold, T Büchner, et al.
Leukemia|January 23, 2009
The homeobox gene CDX2 is aberrantly expressed and associated with an inferior prognosis in patients with acute lymphoblastic leukemiaS Thoene, V P S Rawat, B Heilmeier, et al.
Der Internist|October 1, 1996
[Acute lymphatic leukemia of the adult. Diagnosis, risk groups and therapy]D Hoelzer, N Gökbuget, R Arnold, et al.
Blood Cancer Journal|July 26, 2012
Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutationsM Neumann, S Heesch, N Gökbuget, et al.
Blood|November 26, 1999
A randomized, double-blind, placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as an adjunct to chemotherapy for adults with de novo acute myeloid leukemiaE Archimbaud, O G Ottmann, J A Yin, et al.
Vnitrni Lekarstvi|April 17, 2010
[Treatment of adult acute lymphoblastic leukemia according to GMALL 07/2003 study protocol in the Czech Republic - the first experience]F Folber, C Sálek, M Doubek, et al.
Pageof 42